Acadian Asset Management’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $525K | Sell |
1,267,999
-28,332
| -2% | -$11.7K | ﹤0.01% | 1126 |
|
|
2025
Q1 | $806K | Buy |
1,296,331
+186,883
| +17% | +$116K | ﹤0.01% | 981 |
|
|
2024
Q4 | $1.85M | Buy |
1,109,448
+683,024
| +160% | +$1.14M | 0.01% | 783 |
|
|
2024
Q3 | $773K | Buy |
+426,424
| New | +$773K | ﹤0.01% | 981 |
|
|
2022
Q3 | – | Sell |
-20,955
| Closed | -$170K | – | 1662 |
|
|
2022
Q2 | $170K | Buy |
+20,955
| New | +$170K | ﹤0.01% | 1236 |
|